Physician profile
Farooq Junaid
NPI 1720328842
$3,742.16
in general payments reported to CMS, 2019-2025
25 companies · $513 in 2025
The $513 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,181 · 2020: $472 · 2021: $86.97 · 2022: $258 · 2023: $634 · 2024: $598 · 2025: $513.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,744.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,744.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $553.38 | 2019-2025 | Mitraclip, Jot Dx |
| Novartis Pharmaceuticals Corporation | $537.28 | 2019-2025 | |
| Edwards Lifesciences Corporation | $437.83 | 2019-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boston Scientific Corporation | $398.05 | 2019-2025 | Watchman Access System |
| Pfizer INC. | $361.63 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $338.36 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $156.74 | 2023-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $146.78 | 2019-2024 | Camzyos, Eliquis |
| Medtronic, INC. | $141.46 | 2023 | Corevalve Evolut R, Linq II |
| Amgen INC. | $101.44 | 2024-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $98.61 | 2020-2024 | Brilinta, Farxiga |
| Heartflow, INC. | $95.94 | 2022-2025 | |
| Esperion Therapeutics, INC. | $84.92 | 2020 | |
| Kiniksa Pharmaceuticals International, Plc | $43.99 | 2024 | Arcalyst |
| Novo Nordisk INC | $41.81 | 2025 | Wegovy |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $35.32 | 2019 | |
| Lantheus Medical Imaging, INC. | $29.71 | 2023 | Definity |
| Kiniksa Pharmaceuticals, LTD. | $22.94 | 2023 | Arcalyst |
| Philips North America LLC | $19.54 | 2023 | |
| Biobeat USA INC. | $18.45 | 2024 | Bb-613 Bpm Kit |
| Abiomed | $18.21 | 2025 | |
| Inspire Medical Systems, INC. | $17.59 | 2025 | Inspire |
| Scpharmaceuticals INC. | $16.12 | 2024 | |
| Astellas Pharma US INC | $13.88 | 2019 | |
| Irhythm Technologies, INC. | $12.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farooq Junaid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.